Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Transarterial Microembolization

Research Leaders

7 sponsors active, led by Istituto Ortopedico Rizzoli

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07573072Completed

Characterization of the Methylation Profile of Stored Human Samples

NCT07140367RecruitingPrimary

"Transarterial Microembolization (TAME) in Inflammatory Knee Pathology"

NCT06219603CompletedPrimary

Knowledge and Awareness About Inflammatory Articular Diseases

Showing all 3 trials

Research Network

Common Treatments

  • Transarterial Microembolization1
  • Survey1

Active Sponsors

  • Istituto Ortopedico Rizzoli2
  • San Salvatore Hospital, AST Pesaro-Urbino1
  • Azienda Ospedaliero-Universitaria, Catania1
  • A.O.U. Città della Salute e della Scienza - Molinette Hospital1
  • Ospedale San Giuseppe Moscati, Avellino1

Related Conditions

  • Knee Osteoarthristis1
  • Sarcoma Of Bone And Connective Tissue1
  • Rare Disorders1

Activity Timeline